ResearchReport profile picture
ResearchReport creëerde nieuwe artikel
10 w

Increasing Availability Of Advanced Clotting Factor Therapies Is Driving Growth In The Hemophilia B Market | #hemophilia B

Increasing Availability Of Advanced Clotting Factor Therapies Is Driving Growth In The Hemophilia B Market

Increasing Availability Of Advanced Clotting Factor Therapies Is Driving Growth In The Hemophilia B Market

Hemophilia B is a rare inherited bleeding disorder caused by a deficiency or dysfunction of clotting factor IX, leading to prolonged bleeding episodes, spontaneous hemorrhages, and joint damage.

© 2026 ukola.live

Language